Allison Gardner MP: speeches 2025

Speeches

• 16 Jul 2025 · Giving Every Child the Best Start in Life · Hansard source

  More

  I commend the Government for their mission to give every child the best start in life. It is critical that all children, no matter where they are born, have every opportunity to achieve their potential. I must mention at this point the number of Staffordshire MPs who are here for the debate, which just shows the importance of this topic to the children in our county.

• 16 Jul 2025 · Giving Every Child the Best Start in Life · Hansard source

  More

  My hon. Friend is right that we hunt as a pack: when the three Stokie MPs get together with our Staffordshire colleagues, we make a formidable bunch, and I am very proud to be part of the team. I am incredibly proud to work for a Labour Government who are breaking down the barriers to opportunity, tackling child poverty and improving early years development through our plan for change. This is certainly a nationwide issue, but I wish to stress the critical importance of this mission in Stoke-on-Trent South and Stoke-on-Trent more widely. Our children were neglected time and again by the previous Government, and we now have some of the worst outcomes for childhood development, health and wellbeing in the country. Before I list the statistics, I want to point out that Stoke-on-Trent is also the best place in the country to live and that the people are fantastic. We have been let down and that is by no means the fault of the wonderful people of Stoke-on-Trent.

• 16 Jul 2025 · Giving Every Child the Best Start in Life · Hansard source

  More

  My hon. Friend quite rightly points out the complexities and histories of the issues that we face, which we need to solve with a holistic approach. In the absence of amazing services such as Sure Start, mentioned by my hon. Friend the Member for Stoke-on-Trent North (David Williams), the predominant policy route has been to fund reactive services that reach families only at crisis point. Not only is that incredibly costly, but it results in so many children with developmental delays or safeguarding concerns going unnoticed until it is far too late. Early years services provide a lifeline to so many families; in their absence, inequalities have risen and our children have suffered. Stoke’s children deserve better. I am deeply grateful to the Minister, who is in her place and who has agreed to have a meeting with me to discuss the difficult problems that we wish to solve. The Government are absolutely working hard to address those. As I said, I am incredibly pleased that this Government are expanding the early years offer through the Best Start family hubs model. I am so grateful that the Government have committed to further support the family hub in Normacot, which the community has fought so hard to save, but families in Meir also deserve a Best Start family hub. Residents in Meir are proud of where they live, but they are aware of the challenges in their community, and they too deserve support. Children in Meir would benefit hugely from a centre in their neighbourhood. We know what works. We know that high-quality early years education and support networks for families can completely transform a child’s life chances. We know that early intervention is far more effective and affordable than trying to fix problems later down the line. We need policies that improve neonatal and post-natal health, provide parents with the knowledge and support to give their children the very best start and provide children with support to achieve their early learning and development goals. I am therefore so grateful for the expansion of early years support through the Best Start family hubs and our targets for early years development under the plan for change. This Government will bring about much-needed change for children across the country, and it is critical that that investment is received in Stoke-on-Trent South.

• 16 Jul 2025 · Giving Every Child the Best Start in Life · Hansard source

  More

  I thank my hon. Friend for mentioning the extra work that so many of our primary schools do. I particularly want to comment on the headteacher of Alexandra infants’ school in Normacot, Adele Lupton, who has for many years had a community room that is open to the community. She has worked so incredibly hard to support children in incredibly difficult circumstances, and has managed to keep her teams together. She is a shining example, as are so many of the wonderful headteachers in Stoke-on-Trent who fight to deliver the services that are so sadly lacking sometimes.

• 15 Jul 2025 · West Coast Main Line · Hansard source

  More

  As my hon. Friend will know, Stoke-on-Trent sits on a side branch of the west coast main line that feeds a conurbation of over 400,000 people, many of whom work in and travel regularly to Manchester, London or Birmingham. Does he agree that any future development of the line must not impact negatively on direct services from Stoke-on-Trent to London and from Stoke-on-Trent to Manchester, which previous plans for HS2 threatened?

• 11 Jul 2025 · Rare Cancers Bill · Hansard source

  More

  Stella Gilbert, née Forster, was a much-beloved wife, mother, grandmother and sister to my partner, Jim. She died of a rare cancer. Stella was great—my partner’s only sibling, a huge matriarch and, as we found out at her funeral, given to bossing her local vicar about. She had bile duct cancer, which affects approximately 2,000 people a year in the UK. In the Bill’s terms, bile duct cancer is a rare cancer; the Bill classes rare cancers as those that affect no more than one in 2,000 people, and bile duct cancer affects 0.06 in 2,000. Worryingly, research suggests that that incidence is increasing. I am grateful that the Bill allows for some flexibility, because if bile duct cancer were to pop over that cut-off of one in 2,000, it would go into a different category. That flexibility is appreciated. Guts UK states that the cause of bile duct cancer is unknown in six to seven out of 10 patients. It is a rare cancer that is increasing in prevalence, often with causes unknown, and nearly 3,000 people a year die from it. Would it not be better therefore not only to prevent this cancer from increasing in prevalence, but to make it even rarer and more curable? The Bill opens the door to that. It will allow for more focus on rare and less survivable cancers. Research is crucial in tackling cancer, and I am heartened by this Government’s commitment to tackling all cancer types. A national cancer plan is due to be published following the NHS 10-year health plan, and the DHSC has committed more than £1.6 billion for research to the National Institute for Health and Care Research, which is quite rightly treating cancer as a major priority and allocating funding accordingly. As an officer of the all-party parliamentary group on the less survivable cancers, I am particularly grateful for the commitment to tackling brain cancer, which I have heard a lot about in this place today, in partnership with organisations such as the Tessa Jowell Brain Cancer Mission and Brain Tumour Research. I also welcome the funding call for the brain tumour research consortium, which I read about recently. I cannot stand in this place and debate a Bill on rare cancers and not mention pancreatic cancer, which is a relatively rare cancer and a less survivable one. It is the fifth biggest cancer killer in the UK. My mum, Breeda, died of pancreatic cancer. She fell ill on a Saturday, was diagnosed on the Sunday and was dead by the following Saturday. One week after that, my father died of oesophageal cancer—not a rare cancer, I believe, but a less survivable one. My sister’s mother-in-law, Doreen, also sadly passed from pancreatic cancer after a year-long battle. We are, indeed, surrounded by cancer. The APPG has addressed the issue of the early detection of such cancers, so we hope to one day hear fewer stories like my mum’s. I thank Pancreatic Cancer UK for its support. I welcome the Bill, which offers an entirely reasonable set of steps for researching, reviewing and, I hope, enabling the development of so-called orphan drugs—like my hon. Friend the Member for Edinburgh South West (Dr Arthur), I dislike the term intensely. The appointment of a national specialty lead for rare cancers will be so helpful in and of itself. In passing the Bill today, we will start the journey to a world where wonderful people, like Jim’s sister Stella, my mum Breeda and my sister’s mother-in-law Doreen, do not hear the words, “It is inoperable. It is too late to treat. There is nothing more we can do.” I thank my hon. Friend the Member for Edinburgh South West for introducing the Bill. I will vote for it today, in memory of Stella, Breeda and Doreen.

• 7 Jul 2025 · Giving Every Child the Best Start in Life · Hansard source

  More

  I really welcome the statement today, as I am sure do the residents of Normacot, whose excellent family hub they fought hard to save many years ago. But we need more in my constituency of Stoke-on-Trent South. Stoke-on-Trent consistently lags behind the national average. Many children start school unable to speak, and infant mortality rates are the highest in the country. We consistently rank highest for the number of children in care across England, and in some parts of my constituency, child poverty is as high as 76%. Stoke’s children deserve better. The Best Start hubs offer an opportunity to improve health, to help children reach their development goals and to improve parental wellbeing. Will the Minister meet me to discuss the critical need for more of these hubs in my constituency?

• 26 Jun 2025 · Bus Services (No. 2) Bill [ Lords ] (Third sitting) · Hansard source

  More

  I am really heartened by clause 11 and I welcome it. I am sure the Minister agrees that consulting people who live with disabilities is vital for any future public transport service. Even with the best of intent, one cannot plan accessible services without understanding the lived experience of disabled users and the associated infrastructure.

• 23 Jun 2025 · UK Modern Industrial Strategy · Hansard source

  More

  The industrial strategy rightly recognises the role of ceramics as a key foundational industry and, of course, the central role of Stoke-on-Trent not just historically but in the exciting new world of advanced ceramics—providing parts for wind turbines and even small modular reactors, if we get the investment our way. As the Secretary of State has mentioned, ceramics has the additional challenge of being a gas-intensive industry. As such, I welcome the Government’s commitment to the energy-intensive industries compensation scheme—a snappier name would be nicer—particularly in supporting decarbonisation and technological innovation. May I ask the Secretary of State what specific support is planned to aid the ceramics industry, not only in managing its energy costs but in supporting its decarbonisation?

• 18 Jun 2025 · Post-industrial Towns · Hansard source

  More

  The most recent data, from 2023, showed that 25% of manufacturing jobs in Stoke-on-Trent were in ceramics. Ceramics—especially advanced ceramics—is critical to strategic industries such as defence, nuclear energy and steel. Does my hon. Friend agree that the industrial strategy must recognise the foundational industry of ceramics, which is vital for the future not only of Stoke-on-Trent but the country?

• 13 Jun 2025 · Terminally Ill Adults (End of Life) Bill · Hansard source

  More

  I entirely agree with my hon. Friend. To expect MPs to improve the Bill without clarity as to what the regulations are or what they will be, and how the service will be delivered without rigorous regulatory oversight is fundamentally wrong. Furthermore, the fact that the implementation of the Bill will be automatic in 2029—a general election year, incidentally—is not realistic when reflecting on the many areas that still lack detail. Hence I support amendment 42, proposed by my hon. Friend the Member for Newcastle-under-Lyme (Adam Jogee), which allows the Secretary of State to determine the appropriate date for the Bill to be implemented. This would allow time to make the NHS fit for purpose, to strengthen palliative care, and for Parliament to draft and scrutinise adequate regulations without being rushed. Similarly, but fundamental to the society in which we live, amendment 12 protects the status of our most dear institution, the NHS. The Bill before us provides Henry VIII powers to amend the National Health Service Act 2006 without limit, which could include a specification of charges. If, as Labour MPs, we are committed to the NHS remaining free at the point of use, then amendment 12 is vital, as it will require any changes to the 2006 Act to be made by an Act of Parliament. The future is uncertain. We must build safeguards in the Bill to protect us from measures that fundamentally alter the fabric of our society. Briefly, amendment 27 requires the MHRA to license the drugs used for assisted dying. Research has shown that painful and protracted deaths via assisted dying drugs are not uncommon, with deaths ranging from three minutes to 137 hours—nearly a week— with up to eight hours to lose consciousness. Furthermore, serious side effects disproportionately affect younger people. Amendment 27 will help to ensure the safety and efficacy of these substances. I will close by quoting Sir David Haslam on how we balance some of the individual stories used on both sides of the debate with the good of society. As we know, NICE has to make the difficult decision to approve or not approve medications and treatments based on a cost and clinical effectiveness model. It is experienced in weighing up societal good— [ Interruption. ] I will be quick, Madam Deputy Speaker—versus the needs and wishes of individuals.

• 13 Jun 2025 · Terminally Ill Adults (End of Life) Bill · Hansard source

  More

  I rise to support a number of new clauses and amendments to the Bill. The common thread running through all of them is a need to address some of the gaps in the safeguards and oversight. Should the Bill pass, I at least want to ensure that we improve its protections and remove some of the risks that it contains. New clause 4 requires the chief medical officer to monitor the operation of the legislation, rather than depending solely on the assisted dying commissioner. Alongside the requirement for a High Court judge, oversight by the CMO was removed during the Committee stage. This means that, essentially, the assisted dying commissioner would mark their own homework. New clause 4 returns the safeguard of independent oversight, which is sensible given the significant concerns expressed by many experts and organisations, which were often neutral on the principle, but concerned about the Bill. They include the Royal College of Psychiatrists, the Association for Palliative Medicine, the British Geriatrics Society, the Royal College of Physicians and many experts such as Professor Jane Monckton Smith, a leading criminologist, Baroness Finlay, Parliament’s leading expert on palliative care, Sir David Haslam, former head of the British Medical Association and of the National Institute for Health and Care Excellence—my previous employer—and many more. All have expressed concerns, even when neutral on the principle of the adequacy of the Bill. Hence new clause 4 requires an annual report to include “information about the application of the Act in relation to— persons who have protected characteristics, and any other description of persons specified in regulations made by the Secretary of State.” I fervently hope that that includes domestic violence victims. Amendment 13 very sensibly adds the requirement that the commissioner appointment is not the sole remit of the Prime Minister at the time, by requiring the consent of the Health and Social Care Committee. This provides a safeguard against ideological and politically motivated appointments, and I would be very critical of anyone who would want to prevent that. Amendment 15 addresses the significant concerns about the involvement of private—for profit—providers of assisted dying. There are concerns that, when there is a commercial relationship between providers, there will be a gaming of the system. That risks compromising the relationship between the co-ordinating doctor and the independent doctor. Likewise, the existence of such providers does not allay concerns about doctor shopping, as was raised in the previous debate. Hence amendment 15 will require private providers to be transparent and provide reports on service members, service numbers, costs and revenue. In previous debates and in the public discourse I have found it very disconcerting that, in response to legitimate concerns, all that we have been offered—as we have seen today—are some promised, unspecified future regulations that will fix the gap—[Hon. Members: “Hear, hear!”]

• 10 Jun 2025 · Rooftop Solar Power · Hansard source

  More

  Happy birthday, Mr Speaker. In my Stoke-on-Trent South constituency, businesses such as the Bestway Group, which owns Well healthcare in Meir Park, and Goodwin International in Newstead are keen to invest in rooftop solar, but they cannot get national grid connectivity. In the case of Well healthcare, it will have to wait until 2032. Meanwhile, residents in my village areas are frustrated at the growth of solar farms on agricultural land when there are acres of empty flat roofs on industrial estates. Will the Secretary of State meet me to discuss the many challenges and opportunities for transitioning to clean energy that businesses in my constituency face?

• 10 Jun 2025 · Rooftop Solar Power · Hansard source

  More

  8. What steps he is taking to support rooftop solar power projects.

• 4 Jun 2025 · Disadvantaged Communities · Hansard source

  More

  Child poverty rates in Florence in my constituency have reached over 60% in recent years—the highest rate across Stoke-on-Trent, which routinely scores highest for infant mortality rates. Does my hon. Friend agree that as we publish the child poverty strategy in the autumn, Stoke-on-Trent South needs sustained investment to tackle high rates of child poverty?

• 4 Jun 2025 · Product Regulation and Metrology Bill [Lords] · Hansard source

  More

  The hon. Member is right to point out that Stoke and Staffordshire are not the only places that produce wonderful ceramic and other products. I understand that new clause 4 is broad in scope. I am speaking today to new clause 1, which relates to ceramics. I hope he will indulge me. A few months ago, I was proud to meet GMB representatives for the British pottery industries here in Parliament, along with my hon. Friends the Members for Stoke-on-Trent North (David Williams) and for Stoke-on-Trent Central (Gareth Snell). That included the formidable Sharon Yates, who is one of my constituents. They have real pride, real passion and real skill in what they do.

• 4 Jun 2025 · Product Regulation and Metrology Bill [Lords] · Hansard source

  More

  I thank my hon. Friend for that timely and right intervention. I join him in his campaign. We do not always have the level of detail needed in this country, and we need to address that nuance so that consumers know exactly what they are buying. That is important, because the pottery industry is at great risk from cheap imports, which are undermining our British-made products and creating unfair competition for our better-quality products made in our own country. This china-dumping of products often falsely pretending to be made by our Staffordshire firms—Dunoon being one example—must be stopped. We must back our British industry and our British workers and do what we can to resist such unfair competition.

• 4 Jun 2025 · Product Regulation and Metrology Bill [Lords] · Hansard source

  More

  I commend my hon. Friend for his outstanding advocacy, in particular for the workers of Moorcroft. I know how hard he has been working for them, and I agree that they are a testament to the great skilled craftsmen and women in British manufacturing. Stoke-on-Trent, the Potteries and Staffordshire are globally renowned for our chinaware and tableware. We stand tall among the likes of Limoges in France and Delft in the Netherlands, and we must ensure that we protect that status. We are celebrating Stoke-on-Trent’s 100th anniversary this year and working towards UNESCO creative city status. I hence urge Ministers and the Government to demonstrate their pride and support for this globally renowned industry by supporting new clause 1.

• 4 Jun 2025 · Product Regulation and Metrology Bill [Lords] · Hansard source

  More

  I rise today in support of new clause 1, which deals with a country of origin marking for ceramic products and which my hon. Friend the Member for Stoke-on-Trent Central (Gareth Snell) so eloquently introduced. My constituency is home to “The Great Pottery Throw Down”, based in the wonderful Gladstone Pottery Museum in Longton, and I am so proud to have many great pottery firms in my constituency. Those include Wedgwood, which is famed for its iconic blue jasperware, and Duchess China, which has factories in Longton and Newstead that I was honoured to visit recently. There, I met Jason Simms, who is a 100-mph visionary for the future of ceramics in Stoke-on-Trent and the world. It was a really interesting visit. Duchess, founded in 1888, produces the tableware used in the House of Commons. It is proud of the fact that its products are made in the UK, from clay to table. People buying products produced by Duchess, for example, will see that they say on the bottom, “Fine bone china made in Staffordshire”. The phrasing is deliberate; it clearly informs the purchaser not only of the product’s country of origin, but the precise part of the country that it comes from. Most of our ceramic products contain these backstamps to mark authenticity, and many include a reference to Stoke and Staffordshire. As I have before, I invite all colleagues to join the “turnover club” and check the backstamp on the chinaware here. They will probably find it was made in Stoke.

• 4 Jun 2025 · Product Regulation and Metrology Bill [Lords] · Hansard source

  More

  Does the Minister agree that online marketplaces should have a greater responsibility to ensure the safety and authenticity of the products they sell, just like a retailer on our high streets?

• 21 May 2025 · Chronic Urinary Tract Infections · Hansard source

  More

  As hon. Members may have guessed, this debate is not only important to thousands of women across the country—according to the Chronic Urinary Tract Infection Campaign, about 1.7 million women suffer from chronic UTIs—but incredibly personal to me. I have suffered from UTIs as a result of menopause for more than 10 years, and received a diagnosis of chronic UTI in 2023. I do not think many people realise how debilitating and excruciating chronic UTI can be. At my worst, I wondered how I could go on. I even changed from a beloved lecturing job to one at NICE because I wanted to change things from within, and it is why I am an MP now. I have tried almost everything; I was even considering—as a final step before the final, final step—having my bladder removed. Although my NHS consultant gave me Hiprex—methenamine hippurate—thank God, which is life-changing for me, he finally shrugged his shoulders and said that I would just have to live with this condition. In desperation, I tracked down a specialist who worked in private practice. How lucky I was to have the money. I can confidently claim that Dr Catriona Anderson saved my life, which I do not say lightly. Chronic UTIs can lead to hospitalisation—I have been twice—and sepsis and death. I have a long list of all the drugs that I am on, but I will not read it out. I believe this is another case of how women’s medical conditions continue to be misunderstood, under-researched and underfunded. To illustrate that point, there is a belief that UTIs are more serious in men than in women. I acknowledge that men’s physiology—men have a longer urethra than women—means that they are less likely to develop a UTI, although the possible presence of an enlarged prostate means that they may experience restrictive urine flows and develop a UTI. That is certainly the case in older men. Consequently, all men are recommended seven-day courses of antibiotics compared with the three-day courses that women are recommended. By the way, there are three antibiotics to treat UTIs. Trimethoprim and nitrofurantoin are the top ones, but I am allergic to them, so I am on cephalexin when I need it. There is a lack of acknowledgement that poorly treated UTIs can lead to bacteria becoming embedded in bladders. Incidentally, a much shorter journey in women means that the diligence afforded to men is not afforded to women. In addition, women’s immune response to pathogenic bacteria in the bladder is oestrogen-dependent, and so it is also age-related. Lack of official recognition of chronic UTIs means that women do not receive treatment equal to what men. I am a molecular biologist, but I will not bore Members by setting out the different types of receptors in the urethral lining of the bladder. I will further illustrate this point in simpler terms. A campaigner told me how her doctor, who repeatedly prescribed her three-day antibiotic courses for her chronic UTI, prescribed her husband, when he presented with a UTI for the first time, a month-long course, which would entirely clear the infection, of course, and minimise risk of recurrence. That says it all. Incidentally, chronic prostatitis is recognised by NICE. As has been mentioned, for many women—approximately 70%—three-day courses will be sufficient, but for rest of women, three-day courses clear only some bacteria. Those that remain are relatively resistant; they then increase in population and there is recurrence. Essentially, repeated short courses establish a system of natural selection for resistant bacteria. It also means that the remaining bacteria then have time to invade the bladder and become embedded, finally leading to chronic UTIs. So, patients are stuck in a loop. The use of the useless urine dipstick test, which is no more accurate than the toss of a coin, and of the midstream urine test, which is even worse, means that infections go undetected. As a result, no antibiotics are prescribed until the infection gets worse and, finally, a short course of antibiotics is prescribed. However, the infection is still not fully cleared, so the loop starts again. The infection then becomes embedded in the bladder wall and chronic UTI develops. Short-term antibiotic courses often do not treat chronic UTIs, because dormant populations of bacteria exist within the bladder wall. Your life revolves around desperately trying to convince doctors to prescribe a course that you know will work for you. I am due to move house soon and I am petrified of having to move GPs, which would mean again starting this battle of trying to convince a GP to take me seriously. I understand concerns around antibiotic resistance and the medical hesitancy in prescribing longer courses of antibiotics. However, the solution is not to minimise antibiotic use; it is to get the diagnosis right, treat thoroughly, recognise the existence of chronic UTIs and prevent their development. I am concerned by the lack of research and guidelines for diagnosis and treatment of chronic UTIs. We could prevent them all together if we get things right. I am particularly excited by the UTI vaccine, which is not currently available in the UK. Prevention of UTIs would not only save the NHS countless hours and money, but save people from living miserable lives. In April, the Minister for Care said in a response to a written question: “there are no current plans to train GPs and urologists on recognising the symptoms of chronic UTIs”. Also, current NICE guidelines do not contain guidance for chronic UTIs. This situation must change. Too many women are being left in unbearable pain without a proper diagnosis or appropriate medication. I will be very quick now, Sir Desmond; you have been very patient with me. About 50% of all antibiotics are prescribed for UTIs. However, each year there are thousands of deaths from UTIs and approximately 200,000 A&E admissions are due to UTI-related illnesses. The cost of UTIs to the NHS, as well as to people’s lives, is huge. This issue is personal for me. It is also personal for the millions living with the pain, frustration and isolation of chronic UTIs. Will the Minister meet me and others, including campaigners, to discuss how we can improve diagnostic tools, develop guidance and ensure that people suffering from this condition receive the care that they deserve? Thank you for your indulgence, Sir Desmond.

• 21 May 2025 · Chronic Urinary Tract Infections · Hansard source

  More

  It is an honour to serve under your chairship, Sir Desmond. I am not well today for the very reason that we are here. I may need to sit down during my speech if that is okay. I am deeply grateful to the hon. Member for Sutton and Cheam (Luke Taylor) for securing this incredibly important debate. [ Interruption. ]

• 16 May 2025 · Terminally Ill Adults (End of Life) Bill · Hansard source

  More

  The Royal College of Psychiatrists states that it does not feel that, at this moment in time, there are sufficient psychiatrists able to take up a position on such a panel. What response does my hon. Friend have to that?

• 15 May 2025 · Business of the House · Hansard source

  More

  My constituent Tina has Rett syndrome and severe scoliosis and needs a new wheelchair. She was measured for one over a year ago but is still waiting to receive it. In my constituency the only option for getting a wheelchair through the NHS is AJM Healthcare. Tina’s mum and dad are not the first constituents to raise with me problems with AJM, and I doubt they will be the last. Will the Leader of the House make time for a debate on how we can improve wheelchair services for constituents such as Tina and Noah—I have mentioned him before—and, importantly, on how we can hold badly performing providers to account?

• 14 May 2025 · Glass Packaging: Extended Producer Responsibility · Hansard source

  More

  There are wider issues with EPR, including for innovative companies supplying new types of packaging. Woolcool produces wool-based packaging that is compostable and biodegradable, but it is classed as worse than polystyrene because it is so innovative that it is unclassified. Will the Minister agree to look into that?